THE METABOLIX INSTITUTE Trademark

Trademark Overview


On Friday, June 7, 2024, a trademark application was filed for THE METABOLIX INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the THE METABOLIX INSTITUTE trademark a serial number of 98590379. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 25, 2026. This trademark is owned by Dixit Medical, Inc.. The THE METABOLIX INSTITUTE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates

Health assessment services, namely, providing metabolic assessment profiles (MAP) to clients obtained by using a portable metabolic measurement system in the nature of a unique, heart-rate based overview of their own metabolism in order to assist in reaching weight loss, sports performance, health, fitness, and wellness-related goals; Metabolic testing for nutraceutical needs; Pharmaceutical advice
the metabolix institute

General Information


Serial Number98590379
Word MarkTHE METABOLIX INSTITUTE
Filing DateFriday, June 7, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, February 25, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLEINSTITUTE
Goods and ServicesNutraceuticals for use as a dietary supplement; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates
Goods and ServicesHealth assessment services, namely, providing metabolic assessment profiles (MAP) to clients obtained by using a portable metabolic measurement system in the nature of a unique, heart-rate based overview of their own metabolism in order to assist in reaching weight loss, sports performance, health, fitness, and wellness-related goals; Metabolic testing for nutraceutical needs; Pharmaceutical advice

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 7, 2024
Primary Code005
First Use Anywhere DateSunday, September 1, 2024
First Use In Commerce DateTuesday, October 1, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 7, 2024
Primary Code044
First Use Anywhere DateSunday, September 1, 2024
First Use In Commerce DateTuesday, October 1, 2024

Trademark Owner History


Party NameDixit Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90405
US

Trademark Events


Event DateEvent Description
Friday, June 7, 2024NEW APPLICATION ENTERED
Saturday, December 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, December 22, 2024ASSIGNED TO EXAMINER
Monday, December 23, 2024NON-FINAL ACTION WRITTEN
Monday, December 23, 2024NON-FINAL ACTION E-MAILED
Monday, December 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 19, 2025NON-FINAL ACTION WRITTEN
Wednesday, November 19, 2025NON-FINAL ACTION E-MAILED
Wednesday, November 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 9, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 9, 2026TEAS AMENDMENT OF USE RECEIVED
Monday, February 9, 2026USE AMENDMENT FILED
Monday, February 9, 2026AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, February 25, 2026USE AMENDMENT ACCEPTED
Wednesday, February 25, 2026NON-FINAL ACTION WRITTEN
Wednesday, February 25, 2026NON-FINAL ACTION E-MAILED
Wednesday, February 25, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED